Carvacrol ameliorates doxorubicin-induced human cardiomyocyte apoptosis, inflammation and ferroptosis by inhibiting histone deacetylase 6
Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100552
DOI: 10.1016/j.lddd.2026.100552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Jie Li und 2 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, J., Wu, Z., & Jiang, N. (2026). Carvacrol ameliorates doxorubicin-induced human cardiomyocyte apoptosis, inflammation and ferroptosis by inhibiting histone deacetylase 6. Letters in Drug Design & Discovery, 23(9), 100552. https://doi.org/10.1016/j.lddd.2026.100552
Vancouver
Li J, Wu Z, Jiang N. Carvacrol ameliorates doxorubicin-induced human cardiomyocyte apoptosis, inflammation and ferroptosis by inhibiting histone deacetylase 6. Letters in Drug Design & Discovery. 2026;23(9):100552. doi:10.1016/j.lddd.2026.100552
BibTeX
@article{Li2026,
author = {Li, Jie and Wu, Zhenhua and Jiang, Nan},
title = {Carvacrol ameliorates doxorubicin-induced human cardiomyocyte apoptosis, inflammation and ferroptosis by inhibiting histone deacetylase 6},
journal = {Letters in Drug Design & Discovery},
year = {2026},
volume = {23},
number = {9},
pages = {100552},
doi = {10.1016/j.lddd.2026.100552}
}
EUVIMED